Skip to main content
Erschienen in: Head and Neck Pathology 3/2020

16.09.2019 | Original Paper

A Myriad of Scleroma Presentations: The Usual and Unusual

verfasst von: Samy Elwany, Hesham Abdel Fattah, Zeyad Mandour, Ahmed Soliman Ismail, Mostafa Abdelnabi

Erschienen in: Head and Neck Pathology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

To prospectively study a series of scleroma patients with a focus on socioeconomic status, clinical presentation, pathology, microbiology, and treatment. A total of 52 patients diagnosed with scleroma were included in the study. Demographic data of the patients were collected and clinical, radiographic, and histopathologic findings were analyzed. Biopsies from atypical patients were sent for electron microscopic examination. Patients were treated both medically and surgically with clinical follow-up to determine outcomes and the incidence of recurrence. Fifty-two patients were included in the study. There were 23 males (44.2%) and 29 females (55.8%). The highest incidence of scleroma was identified in individuals from poor, rural areas in the third to fourth decades of life. The nose was affected in all cases. Other affected sites included the nasopharynx, soft and hard palate, larynx and trachea, lacrimal passages, skin, and gingiva. Some patients had atypical presentations. Complete follow-up of all patients was hindered by non-compliance with clinic visits and the long duration of medical treatment. Recurrence or relapse of the granulomatous lesions after initial improvement occurred in 11 patients (21.2%) within 1 to 3 years. Scleroma is a stubborn, chronic, granulomatous bacterial disease. The diverse presentations may mimic neoplasms and other granulomatous conditions. We present cases with unusual presentations and demonstrate the transmission electron microscopic features of these lesions. Furthermore, we confirm the importance of achieving full eradication of the etiologic bacilli to prevent recurrent disease.
Literatur
1.
Zurück zum Zitat Hoffman EO, Harkin JC. The Mikulicz cell in rhinoscleroma. Am J Pathol. 1973;73:147–53. Hoffman EO, Harkin JC. The Mikulicz cell in rhinoscleroma. Am J Pathol. 1973;73:147–53.
3.
Zurück zum Zitat El Mofty A, Imam A, Botros G, Hamiltom PK, Floyd T. Scleroma in Egypt. Ann Otol Rhinol Laryngol. 1954;63:1031–6.CrossRef El Mofty A, Imam A, Botros G, Hamiltom PK, Floyd T. Scleroma in Egypt. Ann Otol Rhinol Laryngol. 1954;63:1031–6.CrossRef
4.
Zurück zum Zitat Gafaar HA, Gafaar AH, Nour YA. Rhinoscleroma: an updated experience through the last 10 years. Acta Otolaryngol. 2007;131:440–6.CrossRef Gafaar HA, Gafaar AH, Nour YA. Rhinoscleroma: an updated experience through the last 10 years. Acta Otolaryngol. 2007;131:440–6.CrossRef
6.
Zurück zum Zitat Tapia Acana R. Endoscopy of the air passages with special reference to scleroma. Ann Otol Rhinol Laryngol. 1973;982:765–9. Tapia Acana R. Endoscopy of the air passages with special reference to scleroma. Ann Otol Rhinol Laryngol. 1973;982:765–9.
8.
Zurück zum Zitat Badrawy B, Safwat F, Fahmy S. Affection of cervical lymph nodes in rhinoscleroma. J Laryngol Otol. 1974;88:261–9.CrossRefPubMed Badrawy B, Safwat F, Fahmy S. Affection of cervical lymph nodes in rhinoscleroma. J Laryngol Otol. 1974;88:261–9.CrossRefPubMed
9.
Zurück zum Zitat Hara JH, Lonser ER. Scleroma-Masquerading as intracranial meningioma. Arch Otolaryngol. 1964;79:742–5. Hara JH, Lonser ER. Scleroma-Masquerading as intracranial meningioma. Arch Otolaryngol. 1964;79:742–5.
10.
Zurück zum Zitat Bahri HC, Bassi NK, Rohatgi MS. Scleroma with intracranial extension. Ann Otol. 1972;81:856–9. Bahri HC, Bassi NK, Rohatgi MS. Scleroma with intracranial extension. Ann Otol. 1972;81:856–9.
12.
Zurück zum Zitat Atef A, Talaat N, El Farouk A, Qotb M, Fathi H, Ilia S. Sinus involvement of rhinoscleroma: a cause of antibiotic resistance and early recurrence after medical treatment. Egypt J Otolaryngol. 2012;28:8–11. Atef A, Talaat N, El Farouk A, Qotb M, Fathi H, Ilia S. Sinus involvement of rhinoscleroma: a cause of antibiotic resistance and early recurrence after medical treatment. Egypt J Otolaryngol. 2012;28:8–11.
13.
Zurück zum Zitat Avery RK, Salman SD, Baker AS. Rhinoscleroma treated with ciprofloxacin: a case report. Laryngoscope. 1995;105:854–6.CrossRefPubMed Avery RK, Salman SD, Baker AS. Rhinoscleroma treated with ciprofloxacin: a case report. Laryngoscope. 1995;105:854–6.CrossRefPubMed
14.
Zurück zum Zitat Badrawy R. The uvula sign in scleroma of the nasopharynx. Ann Otol Rhinol Laryngol. 1965;74:441–4.CrossRefPubMed Badrawy R. The uvula sign in scleroma of the nasopharynx. Ann Otol Rhinol Laryngol. 1965;74:441–4.CrossRefPubMed
15.
Zurück zum Zitat Sedano HO, Carlos RB, Koutlas IG. Respiratory scleroma: a clinicopathologic and ultrastructural study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:665–71.CrossRefPubMed Sedano HO, Carlos RB, Koutlas IG. Respiratory scleroma: a clinicopathologic and ultrastructural study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:665–71.CrossRefPubMed
16.
Zurück zum Zitat Ahmed A, El-Badawy Z, Mohamed I, Abdelhameed W. Rhinoscleroma: a detailed histopathological diagnostic insight. Int J Clin Exp Path. 2015;8:8438–45. Ahmed A, El-Badawy Z, Mohamed I, Abdelhameed W. Rhinoscleroma: a detailed histopathological diagnostic insight. Int J Clin Exp Path. 2015;8:8438–45.
17.
Zurück zum Zitat Toppzada HH, Gafaar H, El-Ghazawi I. The role of plasma cells in rhinosc;eroma. ORL. 1977;39:1–13.CrossRef Toppzada HH, Gafaar H, El-Ghazawi I. The role of plasma cells in rhinosc;eroma. ORL. 1977;39:1–13.CrossRef
18.
Zurück zum Zitat Gafaar H, Harada Y. Rhinoscleroma: a scanning electrom microscopic study. ORL. 1976;38:350–7.CrossRef Gafaar H, Harada Y. Rhinoscleroma: a scanning electrom microscopic study. ORL. 1976;38:350–7.CrossRef
19.
Zurück zum Zitat Miller RH, Shulman JB, Canalis RF, Ward PH. Klebsiella rhinoscleromatis: a clinical and pathogenic enigma. Otolaryngol Head Neck Surg. 1979;87:212–21.CrossRefPubMed Miller RH, Shulman JB, Canalis RF, Ward PH. Klebsiella rhinoscleromatis: a clinical and pathogenic enigma. Otolaryngol Head Neck Surg. 1979;87:212–21.CrossRefPubMed
20.
Zurück zum Zitat Badrawy R. The uvula sign in scleroma of the nasopharynx. Ann Otol. 1965;74:441–4. Badrawy R. The uvula sign in scleroma of the nasopharynx. Ann Otol. 1965;74:441–4.
21.
Zurück zum Zitat Soni NK. Scleroma of the lower respiratory tract: a bronchoscopic study. J Laryngol Otol. 1994;108:484–5.CrossRefPubMed Soni NK. Scleroma of the lower respiratory tract: a bronchoscopic study. J Laryngol Otol. 1994;108:484–5.CrossRefPubMed
22.
Zurück zum Zitat Afaro-Monge JM, Fernandez-Espinosa J. Scleroma of the lower respiratory tract: case report and review of the literature. J Laryngol Otol. 1994;108:161–3.CrossRef Afaro-Monge JM, Fernandez-Espinosa J. Scleroma of the lower respiratory tract: case report and review of the literature. J Laryngol Otol. 1994;108:161–3.CrossRef
23.
Zurück zum Zitat Amoils CP, Shindo ML. Laryngotracheal manifestations of rhinoscleroma. Ann Otol Laryngol. 1996;106:336–40.CrossRef Amoils CP, Shindo ML. Laryngotracheal manifestations of rhinoscleroma. Ann Otol Laryngol. 1996;106:336–40.CrossRef
24.
25.
Zurück zum Zitat Badrawy R. Dacryoscleroma (scleroma of the lachrymal passages). An Otol Rhionl Laryngol. 1962;71:247–54.CrossRef Badrawy R. Dacryoscleroma (scleroma of the lachrymal passages). An Otol Rhionl Laryngol. 1962;71:247–54.CrossRef
Metadaten
Titel
A Myriad of Scleroma Presentations: The Usual and Unusual
verfasst von
Samy Elwany
Hesham Abdel Fattah
Zeyad Mandour
Ahmed Soliman Ismail
Mostafa Abdelnabi
Publikationsdatum
16.09.2019
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 3/2020
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-019-01075-5

Weitere Artikel der Ausgabe 3/2020

Head and Neck Pathology 3/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Molekularpathologische Untersuchungen im Wandel der Zeit

11.04.2024 | Pathologie | Schwerpunkt: Next Generation Pathology

Vergleichende Pathologie in der onkologischen Forschung

Open Access 08.04.2024 | GIST | CME

Gastrointestinale Stromatumoren

Wo stehen wir?

03.04.2024 | Zielgerichtete Therapie | Schwerpunkt: Next Generation Pathology

Personalisierte Medizin in der Onkologie